Business Standard

A viral message in the Moderna story

In The Messenger, The Wall Street Journal reporter Peter Loftus charts the journey of Moderna from being a languishing biotech start-up to one of the biggest financial beneficiaries of the pandemic

The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World
Premium

The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World

Prosenjit Datta
The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World
Author: Peter Loftus
Publisher: Harvard Business Review Press
Pages: 269
Price: Rs 1,250

For anyone who has followed, even casually, the trajectory of the Coronavirus pandemic, Moderna is a household name today because of its mRNA vaccine. Yet at the end of 2019, it was a languishing biotech start-up with no real products and dismal financials. mRNA was an exciting area from the science point of view. But Moderna had been in existence for a decade and investors were getting more than slightly disillusioned by it. It had raised funding

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in